Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 408 record(s)

Req # A-2020-00032

Briefing Note prepared for the Minister: MR2020-00121 Memorandum to the Minister Re: Alberta Gender-Based Violence Projects.

Organization: Women and Gender Equality Canada

5 page(s)
January 2021

Req # A-2020-00034

Briefing Note prepared for the Minister: MR2020-00034 New Projects under the Gender -Based Violence Program.

Organization: Women and Gender Equality Canada

8 page(s)
January 2021

Req # A-2020-00087

Briefing Notes prepared for the Minister: MR2020-00330 - Speaking Notes for the Saskatchewan National Online Session - Violence Against Indigenous Women and Girls: Responding to the National Inquiry's Calls for Justice.

Organization: Women and Gender Equality Canada

11 page(s)
January 2021

Req # A-2020-00091

Briefing Notes prepared for the Minister: # MR2020-00221 - Meeting with Minister Fortier.

Organization: Women and Gender Equality Canada

1 page(s)
January 2021

Req # A-2020-00140

I am looking for information about Status of Women Canada’s (now Women and Gender Equality Canada) Women's Program and Women's Community Fund for the period of fiscal years 1995-1996 to 2015-2016. I am looking for: Request for final proposal guides and or blank application forms that were required to be completed for consideration for funding for each year 1995-1996 to 2015-2016. Final List of funded organizations for each year specific to funding related to violence, including description of funded project or program and amount of funding received. The report that was formerly available on Status of Women Website. Status of Women conducted online, regional and national consultations on gender equality and the Women Program from September to November 2005. The report is no longer online. This is mentioned in the Departmental Performance Report 2005-2006. Please provide electronic copies only.

Organization: Women and Gender Equality Canada

49 page(s)
January 2021

Req # A-2020-18432

Copies of the daily calendar meetings, calls and other taskings for Mitchell Levine from June 1, 2019 to November 18, 2020.

Organization: Patented Medicine Prices Review Board Canada

84 page(s)
December 2020

Req # A-2020-18433

Copies of the daily calendar meetings, calls and other taskings for Melanie Bourassa-Forcier from June 1, 2019 to November 18, 2020.

Organization: Patented Medicine Prices Review Board Canada

18 page(s)
December 2020

Req # A-2020-18434

Copies of all completed Access to Information requests: A-2018-001, A-2018-002, A-2018-003, A-2018-004 and A-2019-0003.

Organization: Patented Medicine Prices Review Board Canada

1978 page(s)
December 2020

Req # A-2020-18435

All briefing notes, memos, PowerPoints, policy briefs and reports submitted to the ISED Minister from June 1, 2019 to November 19, 2020.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
December 2020

Req # A-2020-18442

A detailed summary of all occasions the PMPRB has used the excessive price penalty for pharmaceutical companies, broken down by date, company penalized, the name of the drug in question, the amount penalized, and a summary of why the price was excessive. Additionally, provide details of how much was collected under the penalty for the past five years and how the money gained from the penalties was used.

Organization: Patented Medicine Prices Review Board Canada

2 page(s)
December 2020
Date modified: